[go: up one dir, main page]

ZA200710600B - Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones - Google Patents

Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones

Info

Publication number
ZA200710600B
ZA200710600B ZA200710600A ZA200710600A ZA200710600B ZA 200710600 B ZA200710600 B ZA 200710600B ZA 200710600 A ZA200710600 A ZA 200710600A ZA 200710600 A ZA200710600 A ZA 200710600A ZA 200710600 B ZA200710600 B ZA 200710600B
Authority
ZA
South Africa
Prior art keywords
fumagillin
bioavailability
derivatives
increase
macrocyclic lactones
Prior art date
Application number
ZA200710600A
Other languages
English (en)
Inventor
Alvinerie Michel
Dupuy Jacques
Lespine Anne
Sutra Jean-Francois
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Publication of ZA200710600B publication Critical patent/ZA200710600B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200710600A 2005-06-08 2006-06-08 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones ZA200710600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0505829A FR2886855B1 (fr) 2005-06-08 2005-06-08 Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques

Publications (1)

Publication Number Publication Date
ZA200710600B true ZA200710600B (en) 2009-05-27

Family

ID=35064492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200710600A ZA200710600B (en) 2005-06-08 2006-06-08 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones

Country Status (9)

Country Link
US (2) US20080200402A1 (xx)
EP (1) EP1888116A2 (xx)
AU (1) AU2006256616A1 (xx)
BR (1) BRPI0611642A2 (xx)
CA (1) CA2611201A1 (xx)
FR (1) FR2886855B1 (xx)
MX (1) MX2007015504A (xx)
WO (1) WO2006131649A2 (xx)
ZA (1) ZA200710600B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2731020A1 (en) 2008-07-18 2010-01-21 Zafgen, Inc. Use of antiangiogenic fumagillins in the treatment of obesity
WO2010065883A2 (en) 2008-12-04 2010-06-10 Zafgen Corporation Method of treating an overweight or obese subject
US20120004162A1 (en) 2008-12-04 2012-01-05 Vath James E Methods of Treating an Overweight or Obese Subject
KR20120083905A (ko) 2009-10-09 2012-07-26 자프겐 코포레이션 비만의 치료에 사용하기 위한 설폰 화합물
CA2786603C (en) 2010-01-08 2018-02-20 James E. Vath Fumagillol type compounds and methods of making and using same
WO2011085198A1 (en) 2010-01-08 2011-07-14 Zafgen Corporation Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
KR20130043207A (ko) 2010-07-22 2013-04-29 자프겐 인크. 트리시클릭 화합물 및 이의 제조 및 사용 방법
PH12013500934A1 (en) 2010-11-09 2022-10-24 Zafgen Inc Crystalline solids of a metap-2 inhibitor and methods of making and using same
CA2819251A1 (en) 2010-11-29 2012-06-07 Zafgen Corporation Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
CA2825408A1 (en) 2011-01-26 2012-08-02 Zafgen, Inc. Tetrazole compounds and methods of making and using same
JP5876513B2 (ja) 2011-03-08 2016-03-02 ザフゲン，インコーポレイテッド オキサスピロ［２．５］オクタン誘導体および類似体
WO2012150543A1 (en) 2011-05-02 2012-11-08 Universite De Geneve Macrocyclic lactones and use thereof
BR112013028665A2 (pt) 2011-05-06 2016-09-06 Zafgen Inc compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
KR101979039B1 (ko) 2011-05-06 2019-05-15 자프겐 인크. 부분 포화된 삼환식 화합물 및 그리고 그의 제조방법 및 그를 이용하는 방법
BR112013028666A2 (pt) 2011-05-06 2017-08-08 Zafgen Inc compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo
EP2763671A2 (en) 2011-10-03 2014-08-13 Zafgen, Inc. Methods of treating age related disorders
BR112014017673A8 (pt) 2012-01-18 2017-07-11 Zafgen Inc Compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
EP2804856B1 (en) 2012-01-18 2017-03-15 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
EP2847176A1 (en) 2012-05-07 2015-03-18 Zafgen, Inc. Polymorphic salt of the oxalate salt of 6 - o - ( 4 - dimethylaminoethoxy) cinnarnoyl fumagillol and methods of making and using same
BR112014028041A2 (pt) 2012-05-08 2017-06-27 Zafgen Inc tratamento de obesidade hipotalâmica com inibidores de metap2
CA2873574A1 (en) 2012-05-09 2013-11-14 Zafgen, Inc. Fumagillol type compounds and methods of making and using same
BR112015010225A2 (pt) 2012-11-05 2017-07-11 Zafgen Inc compostos tricíclicos e seus métodos de produção e utilização
CN104918615B (zh) 2012-11-05 2018-10-12 扎夫根股份有限公司 治疗肝病的方法
US9868717B2 (en) 2012-11-05 2018-01-16 Zafgen, Inc. Tricyclic sulphonamide compounds and methods of making and using same
AU2014236528A1 (en) 2013-03-14 2015-09-24 Zafgen, Inc. Methods of treating renal disease and other disorders
ES2955137T3 (es) 2013-03-14 2023-11-28 Alkermes Pharma Ireland Ltd Profármacos de fumaratos y su uso en el tratamiento de diversas enfermedades
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
CA2940845C (en) 2014-02-24 2019-09-24 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
TW201636342A (zh) 2014-12-19 2016-10-16 武田藥品工業有限公司 煙黴醇衍生物
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
ATE177632T1 (de) * 1993-09-24 1999-04-15 Takeda Chemical Industries Ltd Antineoplastische pharmazeutische zusammensetzung enthaltend ein fumagillolderivat und einen platinkomplex
AP646A (en) * 1995-03-27 1998-04-27 Sanofi Synthelabo Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections.
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
EP1258248A3 (en) * 2001-05-18 2003-06-04 TAP Pharmaceutical Products, Inc. Tumor treatments comprising a fumagillol derivative and a further antineoplastic agent
HUP0203718A2 (hu) * 2002-10-31 2004-08-30 Annamária Szőke Orális adagolású, állatgyógyászati hatóanyagot tartalmazó készítmény, és/vagy táplálékkiegészítő készítmény, eljárás annak előállítására és annak alkalmazása

Also Published As

Publication number Publication date
WO2006131649A2 (fr) 2006-12-14
CA2611201A1 (fr) 2006-12-14
WO2006131649A3 (fr) 2007-06-21
EP1888116A2 (fr) 2008-02-20
MX2007015504A (es) 2008-03-18
US20080200402A1 (en) 2008-08-21
US20110144045A1 (en) 2011-06-16
FR2886855A1 (fr) 2006-12-15
FR2886855B1 (fr) 2009-07-17
BRPI0611642A2 (pt) 2010-09-28
AU2006256616A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
ZA200710600B (en) Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones
IL186837A0 (en) Chromane and chromene derivatives and uses thereof
ZA200709043B (en) Benzodioxane and benzodioxalane derivatives and uses thereof
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
IL186297A0 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
IL185688A0 (en) 39-desmethoxy derivatives of rapamycin
ZA200707427B (en) Flavonoid compounds and uses thereof
SI1828201T1 (sl) Makrociklični derivati kinazolina in njihova uporaba kot MTKI
EP1620419A4 (en) STABILIZED DERIVATIVES OF ASCORBIC ACID
EP1871761A4 (en) SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHOD FOR THEIR USE
IL188449A0 (en) Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease
ZA200800348B (en) Derivatives of seleno-amino acids
PT1898901T (pt) Formas de dosagem estáveis de antimaláricos de espiro- e diespiro-1,2,4-trioxolano
ZA200709307B (en) Spirocyclic heterocyclic derivatives and methods of their use
EP1932527A4 (en) USE OF PHTHALIDE DERIVATIVES
IL180777A (en) Chromen-2- one derivatives, pharmaceutical compositions comprising them and uses thereof
PL1716141T3 (pl) Pochodne benzopiranu, sposób ich wytwarzania i ich zastosowanie
ATE369347T1 (de) Trimere makrocyclisch substituierte halogen- benzolderivate
IL188241A0 (en) Cripowellins and synthetic derivatives thereof used as medicaments
ZA200606598B (en) Coumarin derivative and use thereof
IL183705A0 (en) Macrocyclic quinazole derivatives and their use as mtki
PL1942891T3 (pl) Nowa kombinacja leków jako środek przeciwdepresyjny
GB2420274B (en) Shaft structure of foldable unbrella
HK1112232A (en) Chromane and chromene derivatives and uses thereof
ZA200705046B (en) Macrocyclic quinazole derivatives and their use as MTKI